Perseus Proteomics Inc. (TYO:4882)
153.00
+3.00 (2.00%)
Oct 9, 2026, 3:30 PM JST
Perseus Proteomics Revenue
Perseus Proteomics had revenue of 35.18M JPY in the quarter ending June 30, 2026, with 49.90% growth. This brings the company's revenue in the last twelve months to 147.22M, up 19.70% year-over-year. In the fiscal year ending March 31, 2026, Perseus Proteomics had annual revenue of 135.00M with 12.50% growth. That makes Perseus Proteomics the 43,692nd largest company in the world by revenue and 3,867th in Japan.
Revenue (ttm)
147.22M
Revenue Growth
+19.70%
P/S Ratio
19.15
Revenue / Employee
n/a
Employees
35
Market Cap
2.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 135.00M | 15.00M | 12.50% |
| Mar 31, 2025 | 120.00M | 20.00M | 20.00% |
| Mar 31, 2024 | 100.00M | 6.00M | 6.38% |
| Mar 31, 2023 | 94.00M | 23.00M | 32.39% |
| Mar 31, 2022 | 71.00M | 4.00M | 5.97% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.62T |
| Otsuka Holdings | 2.62T |
| Chugai Pharmaceutical | 1.34T |
| HOYA Corporation | 983.64B |
| Miahelsa Holdings | 25.11B |
| FB Care Service | 11.70B |
| Care Service | 9.72B |
| Platz | 8.29B |